Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results

Current Oncology

Volumn 22, Issue 5, 2015, Pages e336-e341

  Antonangelo, Leila ^a   Sales, R K ^a   Cora A P ^a   Acencio, M M P ^a   Teixeira, L R ^a   Vargas, F S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytology; Pleural effusion; Tumour markers

Indexed keywords

ADENOSINE DEAMINASE; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; TUMOR MARKER;

ADULT; ARTICLE; CYTODIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURA EFFUSION; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PLEURA BIOPSY; PLEURA FLUID; PREDICTIVE VALUE; PROSPECTIVE STUDY; RADIOLOGY; SENSITIVITY AND SPECIFICITY; THORACOSCOPY; TUBERCULOSIS; TUMOR LOCALIZATION;

EID: 84944533617     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.22.2563     Document Type: Article

References (20)

1. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Series: who Classification of Tumours (vol. 7). Geneva, Switzerland: World Health Organization; 2015.
2. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ on behalf of the bts Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(suppl 2):ii32-40.
3. Hooper C, Lee YC, Maskell N on behalf of the bts Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(suppl 2):ii4-17.
4. Kjeldsberg CR, Knight JA. Pleural and pericardial fluids. In: Kjeldsberg CR, Knight JA. Body Fluids: Laboratory Examination of Amniotic, Cerebrospinal, Seminal, Serous and Synovial Fluids. 3rd ed. Chicago, IL: ascp Press; 1993: 159-222.
5. Marel M, Stastny B, Melínová L, Svandová E, Light RW. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest 1995;107:1598-603.
6. Alatas F, Alatas O, Metintas M, et al. Diagnostic value of cea, ca 15-3, ca 19-9, cyfra 21-1, nse and tsa assay in pleural effusions. Lung Cancer 2001;31:9-16.
7. Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004;126:1757-63.
8. Shitrit D, Zingerman B, Shitrit ABG, Shlomi D, Kramer MR. Diagnostic value of cyfra 21-1, cea, ca 19-9, ca 15-3 and ca125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist 2005;10:501-7.
9. Gaspar MJ, De Miguel J, García Díaz JD, Díez M. Clinical utility of a combination of tumor markers in the diagnosis of malignant pleural effusions. Anticancer Res 2008;28:2947-52.
10. Liang QL, Shi HZ, Qin XJ, Liang XD, Jiang J, Yang HB. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008;63:35-41.
11. Molina R, Bosch X, Auge JM, et al. Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site. Tumour Biol 2012;33:463-74.
12. Valdés L, Alvarez D, San José E, et al. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998;158:2017-21.
13. Miédougé M, Rouzaud P, Salama G, et al. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer 1999;81:1059-65.
14. Ustün H, Borazan A, Bilgiçli N, Yilmaz A. Diagnostic value of tumoural markers in pleural effusions. Int J Clin Pract 2004;58:22-5.
15. Ferrer J, Villarino MA, Encabo G, et al. Diagnostic utility of cyfra 21-1, carcinoembryonic antigen, ca125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999;86:1488-95.
16. Molina R, Filella X, Jo J, Agusti C, Ballesta AM. ca 125 in biological fluids. Int J Biol Markers 1998;13:224-30.
17. Miralles C, Orea M, España P, et al. Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 2003;10:150-4.
18. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-64.
19. Rosolen DC, Kulikowski LD, Bottura G, et al. Efficacy of two fluorescence in situ hybridization (fish) probes for diagnosing malignant pleural effusions. Lung Cancer 2013;80:284-8.
20. Hsieh TC, Huang WW, Lai CL, Tsao SM, Su CC. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions. Cancer Cytopathol 2013;121:483-8.